Global Information
회사소개 | 문의 | 비교리스트

세계의 나노바디 시장 : 제품 유형별, 애플리케이션별, 유통경로별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년)

Nanobodies Market, by Product Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

리서치사 Coherent Market Insights
발행일 2021년 12월 상품코드 1045543
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,500 ₩ 5,733,000 PDF (Single User License)
US $ 7,000 ₩ 8,919,000 PDF (Multi User License)
US $ 10,000 ₩ 12,742,000 PDF (Enterprise User License)


세계의 나노바디 시장 : 제품 유형별, 애플리케이션별, 유통경로별, 지역별 - 규모, 점유율, 전망, 기회 분석(2021-2028년) Nanobodies Market, by Product Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

기업은 치료용 나노바디(Nanobodies)를 개발하기 위한 연구개발 활동에 주력하고 있으며, 이것이 예측 기간 중 세계 나노바디 시장의 성장을 촉진할 것으로 생각되고 있습니다. 또한 조기진단 및 치료에 대한 의식의 향상도 시장의 성장을 촉진할 것으로 예상됩니다.

세계의 나노바디 시장에 대해 조사했으며, 시장 개요, 시장 역학, 시장 분석, 경쟁 구도 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 목적·전제조건

제2장 시장 개요

  • 리포트 설명
    • 시장의 정의와 범위
  • 개요
    • 시장 내역 : 제품 유형별
    • 시장 내역 : 애플리케이션별
    • 시장 내역 : 유통경로별
    • 시장 내역 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제 및 동향 분석

  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
  • 영향 분석
  • 규제 시나리오
  • PEST 분석
  • 최근 제품 발매/승인
  • 역학
  • 합병과 인수

제4장 COVID-19의 영향 분석

  • 공급망에 대한 영향
  • 연구개발에 대한 영향
  • 정부 구상

제5장 세계의 나노바디 시장 : 제품 유형별(100만 달러)(2017-2028년)

  • 서론
  • 단일 특이성 나노바디
  • 일가 나노바디
  • 다가 나노바디
  • 바이 파라토픽 나노바디
  • 다중 특이성 나노바디
  • 퓨전 나노바디

제6장 세계의 나노바디 시장 : 애플리케이션별(100만 달러)(2017-2028년)

  • 서론
  • 치료
  • 진단

제7장 세계의 나노바디 시장 : 유통경로별(100만 달러)(2017-2028년)

  • 서론
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제8장 세계의 나노바디 시장 : 지역별(100만 달러)(2017-2028년)

  • 서론
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제9장 경쟁 구도

  • 기업 개요
    • Merck KGaA
    • 약제 포트폴리오
    • Sanofi(Ablynx)
    • 약제 포트폴리오
    • Alphamab Oncology
    • 약제 포트폴리오
    • Novartis AG
    • 약제 포트폴리오
    • Genscript
    • 약제 포트폴리오
    • Taisho Pharmaceutical Holdings Co., Ltd.
    • 약제 포트폴리오
    • Sensei Biotherapeutics, Inc.
    • 약제 포트폴리오
    • Cusabio Technology LLC.
    • 약제 포트폴리오
    • ChromoTek GmbH
    • 약제 포트폴리오
    • Beroni Group
    • 약제 포트폴리오
    • ExeVir Bio BV
    • 약제 포트폴리오
    • Absolute Antibody
    • 약제 포트폴리오
    • Alpalife(Shenzhen kangti Co., Ltd.)
    • 약제 포트폴리오
    • DiosCURE Therapeutics SE
    • 약제 포트폴리오
    • Thermo Fisher Scientific Inc.
    • 약제 포트폴리오
    • PerkinElmer, Inc.(BioLegend, Inc.)
    • 약제 포트폴리오
    • Abnova Corporation
    • 약제 포트폴리오
  • 애널리스트의 견해

제10장 섹션

KSA 22.02.04

Nanobodies are engineered antibodies that have a single domain developed by heavy chains with antigen-binding. These antibodies can be engineered and are suitable for various applications for research, therapeutic development, and medical diagnosis due to their size and single-chain nature. Nanobodies have various interesting applications including research on clinical therapeutics. Nanobodies are extensively used in the field of diagnosis and research, and it plays a crucial role and has great potential in noninvasive in vivo imaging. Nanobodies meet requirements to become a generic imaging tracer and offer benefits in molecular imaging, which leads to an increase in the use of nanobodies.

Market Dynamics

Market players are indulged in research and development activities for advancement of nanobodies for therapeutical treatments, which is expected to drive the growth of the global nanobodies market over the forecast period. For instance, according to an article published on Nature Journal on December 21, 2020, researchers at National Institutes of Health isolated a set of nanobodies against SARS-CoV-2. This nanobody is called NIH-CoVnb-112, which binds and blocks the variant form of SARS-Cov-2 spike protein.

Increasing awareness about early diagnosis as well as treatment is expected to drive the growth of the global nanobodies market over the forecast period. For instance, in October 2020, the Government Royapettah Hospital (GRH) organized an awareness program on breast cancer in India. This enabled to increase early detection, diagnosis, and availability of advanced technologies to improve survival rate of patients. This program aimed to create awareness about breast cancer and prevention at an early stage through early detection to avoid further consequences. By using nanobodies, which work as substitutes for naturally occurring antibodies for cancer treatment, they bind to the antigens on the surface of cancer cells, which helps to detect the cancer cells and block their growth. This can help in reducing the prevalence of cancer.

Key features of the study:

  • This report provides an in-depth analysis of global nanobodies market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global nanobodies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Merck KGaA, Sanofi (Ablynx), Alphamab Oncology, Novartis AG, Genscript, Taisho Pharmaceutical Holdings Co., Ltd., Sensei Biotherapeutics, Inc., Cusabio Technology LLC., ChromoTek GmbH, Beroni Group, ExeVir Bio BV, Absolute Antibody, Alpalife (Shenzhen kangti Co., Ltd.), DiosCURE Therapeutics SE, Thermo Fisher Scientific Inc., PerkinElmer Inc. (BioLegend, Inc.), and Abnova Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global nanobodies market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nanobodies market

Detailed Segmentation:

  • Global Nanobodies Market, By Product Type :
    • Mono specific Nanobodies
    • Monovalent Nanobodies
    • Multivalent Nanobodies
    • Bi-paratopic Nanobodies
    • Multi specific Nanobodies
    • Fusion Nanobodies
  • Global Nanobodies Market, By Application:
    • Therapeutic
    • Diagnostic
  • Global Nanobodies Market, By Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Nanobodies Market, By Region:
    • North America
  • By Product Type:
    • Mono specific Nanobodies
    • Monovalent Nanobodies
    • Multivalent Nanobodies
    • Bi-paratopic Nanobodies
    • Multi specific Nanobodies
    • Fusion Nanobodies
  • By Application :
    • Therapeutic
    • Diagnostic
  • By Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • U.S.
    • Canada
    • Latin America
  • By Product Type:
    • Mono specific Nanobodies
    • Monovalent Nanobodies
    • Multivalent Nanobodies
    • Bi-paratopic Nanobodies
    • Multi specific Nanobodies
    • Fusion Nanobodies
  • By Application :
    • Therapeutic
    • Diagnostic
  • By Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • By Product Type:
    • Mono specific Nanobodies
    • Monovalent Nanobodies
    • Multivalent Nanobodies
    • Bi-paratopic Nanobodies
    • Multi specific Nanobodies
    • Fusion Nanobodies
  • By Application :
    • Therapeutic
    • Diagnostic
  • By Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Product Type:
    • Mono specific Nanobodies
    • Monovalent Nanobodies
    • Multivalent Nanobodies
    • Bi-paratopic Nanobodies
    • Multi specific Nanobodies
    • Fusion Nanobodies
  • By Application :
    • Therapeutic
    • Diagnostic
  • By Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • By Product Type:
    • Mono specific Nanobodies
    • Monovalent Nanobodies
    • Multivalent Nanobodies
    • Bi-paratopic Nanobodies
    • Multi specific Nanobodies
    • Fusion Nanobodies
  • By Application :
    • Therapeutic
    • Diagnostic
  • By Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Product Type:
    • Mono specific Nanobodies
    • Monovalent Nanobodies
    • Multivalent Nanobodies
    • Bi-paratopic Nanobodies
    • Multi specific Nanobodies
    • Fusion Nanobodies
  • By Application :
    • Therapeutic
    • Diagnostic
  • By Distribution Channel:
    • Hospitals pharmacies
    • Retails Pharmacies
    • Online Pharmacies
  • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Merck KGaA *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Sanofi (Ablynx)
  • Alphamab Oncology
  • Novartis AG
  • Genscript
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Sensei Biotherapeutics, Inc.
  • Cusabio Technology LLC.
  • ChromoTek GmbH
  • Beroni Group
  • ExeVir Bio BV
  • Absolute Antibody
  • Alpalife (Shenzhen kangti Co., Ltd.)
  • DiosCURE Therapeutics SE
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc. (BioLegend, Inc.)
  • Abnova Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Recent Product Launch/Approval
  • Epidemiology
  • Mergers and Acquisitions

4. COVID - 19 Impact Analysis

  • Impact on Supply Chain
  • Impact on Research and Development
  • Government Initiatives

5. Global Nanobodies Market, By Product Type, 2017-2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Mono specific Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Monovalent Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Multivalent Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Bi-paratopic Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Multi specific Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Fusion Nanobodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)

6. Global Nanobodies Market, By Application, 2017-2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Therapeutic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Diagnostic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)

7. Global Nanobodies Market, By Distribution Channel, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Hospitals Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028, (US$ Million)

8. Global Nanobodies Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • Merck KGaA
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Sanofi (Ablynx)
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Alphamab Oncology
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Novartis AG
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Genscript
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Taisho Pharmaceutical Holdings Co., Ltd.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Sensei Biotherapeutics, Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Cusabio Technology LLC.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • ChromoTek GmbH
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Beroni Group
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • ExeVir Bio BV
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Absolute Antibody
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Alpalife (Shenzhen kangti Co., Ltd.)
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • DiosCURE Therapeutics SE
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Thermo Fisher Scientific Inc.
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • PerkinElmer, Inc. (BioLegend, Inc.)
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Abnova Corporation
    • Company Overview
    • Drug Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q